Clinical Trial Update: The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions. [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 2/Phase 3 study comparing Cypher and Cypher Select sirolimus-eluting coronary stents for treating coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher (sirolimus-eluting coronary stent)
• Cypher Select (sirolimus-eluting coronary stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED